167 related articles for article (PubMed ID: 22301800)
1. Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour.
Straume AH; Løvås K; Miletic H; Gravdal K; Lønning PE; Knappskog S
Eur J Endocrinol; 2012 May; 166(5):941-9. PubMed ID: 22301800
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I, regulating aromatase expression through steroidogenic factor 1, supports estrogen-dependent tumor Leydig cell proliferation.
Sirianni R; Chimento A; Malivindi R; Mazzitelli I; Andò S; Pezzi V
Cancer Res; 2007 Sep; 67(17):8368-77. PubMed ID: 17804753
[TBL] [Abstract][Full Text] [Related]
3. Liver receptor homologue-1 and steroidogenic factor-1 expression in cultured granulosa cells from patients with endometriosis: A preliminary study.
Lu X; Wu ZM; Wang YW; Wang M; Cheng WW
J Obstet Gynaecol Res; 2015 Dec; 41(12):1927-34. PubMed ID: 26530052
[TBL] [Abstract][Full Text] [Related]
4. Localization and regulation of aromatase liver receptor homologue-1 in the developing rat testis.
Sierens J; Jakody I; Poobalan Y; Meachem SJ; Knower K; Young MJ; Sirianni R; Pezzi V; Clyne CD
Mol Cell Endocrinol; 2010 Jul; 323(2):307-13. PubMed ID: 20214950
[TBL] [Abstract][Full Text] [Related]
5. Regulation of aromatase gene expression in Leydig cells and germ cells.
Bourguiba S; Genissel C; Lambard S; Bouraïma H; Carreau S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):335-43. PubMed ID: 14623530
[TBL] [Abstract][Full Text] [Related]
6. Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells.
Catalano S; Malivindi R; Giordano C; Gu G; Panza S; Bonofiglio D; Lanzino M; Sisci D; Panno ML; Andò S
J Biol Chem; 2010 Feb; 285(8):5581-93. PubMed ID: 20026603
[TBL] [Abstract][Full Text] [Related]
7. The promoter(s) of the aromatase gene in male testicular cells.
Carreau S; Bourguiba S; Lambard S; Silandre D; Delalande C
Reprod Biol; 2004 Mar; 4(1):23-34. PubMed ID: 15094793
[TBL] [Abstract][Full Text] [Related]
8. Promoter activity and chromosomal location of the Rana rugosa P450 aromatase (CYP19) gene.
Oshima Y; Kato T; Wang D; Murakami T; Matsuda Y; Nagahama Y; Nakamura M
Zoolog Sci; 2006 Jan; 23(1):79-85. PubMed ID: 16547409
[TBL] [Abstract][Full Text] [Related]
9. TGF-β1 induced activations of Smad2 and miRNAs inhibit SF-1- and LRH-1-dependent CYP19 expression in rat Leydig cells†.
Ma B; Qiao H; Guo Y; Wei J; Yang Q; Feng X; Li Z
Biol Reprod; 2023 May; 108(5):778-790. PubMed ID: 36857632
[TBL] [Abstract][Full Text] [Related]
10. Androgens inhibit aromatase expression through DAX-1: insights into the molecular link between hormone balance and Leydig cancer development.
Maris P; Campana A; Barone I; Giordano C; Morelli C; Malivindi R; Sisci D; Aquila S; Rago V; Bonofiglio D; Catalano S; Lanzino M; Andò S
Endocrinology; 2015 Apr; 156(4):1251-62. PubMed ID: 25603045
[TBL] [Abstract][Full Text] [Related]
11. Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
Abiuso AMB; Varela ML; Haro Durand L; Besio Moreno M; Marcos A; Ponzio R; Rivarola MA; Belgorosky A; Pignataro OP; Berensztein E; Mondillo C
Eur J Cancer; 2018 Mar; 91():125-135. PubMed ID: 29367056
[TBL] [Abstract][Full Text] [Related]
12. Aromatase (Cyp19) expression is up-regulated by targeted disruption of Dax1.
Wang ZJ; Jeffs B; Ito M; Achermann JC; Yu RN; Hales DB; Jameson JL
Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7988-93. PubMed ID: 11427738
[TBL] [Abstract][Full Text] [Related]
13. Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation.
Enjuanes A; Garcia-Giralt N; Supervía A; Nogués X; Ruiz-Gaspà S; Bustamante M; Mellibovsky L; Grinberg D; Balcells S; Díez-Pérez A
Eur J Endocrinol; 2005 Dec; 153(6):981-8. PubMed ID: 16322405
[TBL] [Abstract][Full Text] [Related]
14. Liver receptor homologue-1 expression in ovarian epithelial and granulosa cell tumours.
Chand AL; Pathirage N; Lazarus K; Chu S; Drummond AE; Fuller PJ; Clyne CD
Steroids; 2013 Jul; 78(7):700-6. PubMed ID: 23537609
[TBL] [Abstract][Full Text] [Related]
15. Effects of Neonicotinoid Pesticides on Promoter-Specific Aromatase (CYP19) Expression in Hs578t Breast Cancer Cells and the Role of the VEGF Pathway.
Caron-Beaudoin É; Viau R; Sanderson JT
Environ Health Perspect; 2018 Apr; 126(4):047014. PubMed ID: 29701941
[TBL] [Abstract][Full Text] [Related]
16. Mono-(2-ethylhexyl) phthalate induces NR4A subfamily and GIOT-1 gene expression, and suppresses CYP19 expression in human granulosa-like tumor cell line KGN.
Ohno S; Yukinawa F; Noda M; Nakajin S
Toxicol Lett; 2009 Dec; 191(2-3):353-9. PubMed ID: 19822197
[TBL] [Abstract][Full Text] [Related]
17. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of steroidogenic factor-1/adrenal 4 binding protein and liver receptor homolog-1 (LRH-1)/fetoprotein transcription factor in the rat testis: LRH-1 as a potential regulator of testicular aromatase expression.
Pezzi V; Sirianni R; Chimento A; Maggiolini M; Bourguiba S; Delalande C; Carreau S; Andò S; Simpson ER; Clyne CD
Endocrinology; 2004 May; 145(5):2186-96. PubMed ID: 14736734
[TBL] [Abstract][Full Text] [Related]
19. Abundance of DLK1, differential expression of CYP11B1, CYP21A2 and MC2R, and lack of INSL3 distinguish testicular adrenal rest tumours from Leydig cell tumours.
Lottrup G; Nielsen JE; Skakkebæk NE; Juul A; Rajpert-De Meyts E
Eur J Endocrinol; 2015 Apr; 172(4):491-9. PubMed ID: 25609776
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase A-dependent synergism between GATA factors and the nuclear receptor, liver receptor homolog-1, regulates human aromatase (CYP19) PII promoter activity in breast cancer cells.
Bouchard MF; Taniguchi H; Viger RS
Endocrinology; 2005 Nov; 146(11):4905-16. PubMed ID: 16109788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
